Target intelligence / Profile preview

Vaginal microbiota composition

Molecular classification
Other (it refers to a microbial community/ecosystem, not a single molecule or protein)
01

Overview

Vaginal microbiota composition refers to the distribution and balance of microbial inhabitants within the vagina, primarily bacterial species, which form discrete community state types (CSTs) dominated either by specific Lactobacillus species or by diverse anaerobic bacteria. This ecosystem is dynamic, influenced by hormonal changes, age, sexual activity, and interventions, and its balance is crucial for genital tract health. Imbalances (dysbiosis) are linked to increased risk of infection, adverse reproductive outcomes, and broader health implications. Unlike individual molecular targets, vaginal microbiota composition is an ecological index rather than a conventional drug target or receptor.

Other names
vaginal microbiomevaginal floraVMB
02

Mechanism of action

Antibiotics reduce overgrowth of pathogenic anaerobes Antifungals eliminate pathogenic yeasts Probiotics restore dominance of protective Lactobacillus spp., promote low vaginal pH, and outcompete pathogens

03

Biological functions

Maintenance of genital tract healthDefense against pathogensModulation of local immune responseInfluence on vaginal pH
04

Disease associations

Infection (bacterial vaginosis, vulvovaginal candidiasis, sexually transmitted infections)Pregnancy complications (preterm birth, adverse outcomes)Other (infertility, increased susceptibility to HIV, urinary tract infection)
05

Safety considerations

High recurrence rates after standard antibiotics/antifungalsRisk of microbiome disturbance with broad antimicrobialsResistance development in recurrent infectionsIncomplete understanding of long-term effects of microbiome modulation
06

Interacting drugs

Antibiotics (metronidazole, clindamycin, tinidazole)

2 more in the full profile.

07

Biomarkers

Relative abundance of Lactobacillus species (especially L. crispatus, L. jensenii, L. gasseri, L. iners)Nugent score (microscopy-based surrogate)Vaginal pHDetection of specific pathogens (Gardnerella vaginalis, Atopobium vaginae, etc.)

Beyond the preview

Go deeper on Vaginal microbiota composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal microbiota composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call